Fatemeh Atyabi Selected Research

methotrexate-serum albumin

9/2012	Trastuzumab decorated methotrexate-human serum albumin conjugated nanoparticles for targeted delivery to HER2 positive tumor cells.
7/2012	The in vivo antitumor activity of LHRH targeted methotrexate-human serum albumin nanoparticles in 4T1 tumor-bearing Balb/c mice.
12/2011	Targeted delivery of methotrexate to tumor cells using biotin functionalized methotrexate-human serum albumin conjugated nanoparticles.
1/2011	Use of biotin targeted methotrexate-human serum albumin conjugated nanoparticles to enhance methotrexate antitumor efficacy.
1/2011	Enhanced anti-tumoral activity of methotrexate-human serum albumin conjugated nanoparticles by targeting with Luteinizing Hormone-Releasing Hormone (LHRH) peptide.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Fatemeh Atyabi Research Topics

Disease

71	Neoplasms (Cancer) 02/2022 - 08/2009
33	Breast Neoplasms (Breast Cancer) 01/2022 - 08/2009
9	Wounds and Injuries (Trauma) 01/2021 - 01/2014
8	Neoplasm Metastasis (Metastasis) 10/2020 - 01/2017
6	Inflammation (Inflammations) 01/2019 - 08/2013
5	Colonic Neoplasms (Colon Cancer) 12/2020 - 07/2016
5	Neurodegenerative Diseases (Neurodegenerative Disease) 10/2020 - 12/2013
4	Prostatic Neoplasms (Prostate Cancer) 04/2021 - 01/2010
4	Infections 11/2019 - 12/2010
4	Lung Neoplasms (Lung Cancer) 10/2019 - 07/2015
3	Retinoblastoma (Glioblastoma, Retinal) 04/2022 - 01/2021
3	Melanoma (Melanoma, Malignant) 01/2022 - 05/2020
3	Hypoxia (Hypoxemia) 05/2020 - 06/2018
3	Choroidal Neovascularization 01/2020 - 11/2013
3	Corneal Injuries 01/2019 - 01/2018
3	Human Influenza (Influenza) 11/2018 - 09/2012
3	Ischemic Stroke 01/2018 - 06/2017
3	Alzheimer Disease (Alzheimer's Disease) 01/2018 - 12/2013
2	Nervous System Diseases (Neurological Disorders) 01/2022 - 06/2017
2	Pancreatic Neoplasms (Pancreatic Cancer) 11/2020 - 05/2016
2	Fibrosis (Cirrhosis) 01/2019 - 10/2018
2	Chemical Burns (Chemical Burn) 10/2018 - 09/2017
2	Blindness (Hysterical Blindness) 10/2018 - 01/2011
2	Colorectal Neoplasms (Colorectal Cancer) 06/2018 - 09/2016
2	Brain Ischemia (Cerebral Ischemia) 01/2018 - 12/2017

Drug/Important Bio-Agent (IBA)

33	Small Interfering RNA (siRNA)IBA 02/2022 - 06/2016
31	ChitosanIBA 04/2022 - 10/2010
31	Pharmaceutical PreparationsIBA 01/2022 - 01/2011
12	Docetaxel (Taxotere)FDA Link 04/2021 - 08/2009
8	chitosan lactateIBA 01/2021 - 06/2016
7	VaccinesIBA 02/2022 - 09/2012
7	Folic Acid (Vitamin M)FDA LinkGeneric 02/2022 - 06/2010
7	GoldIBA 01/2022 - 07/2016
7	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 09/2020 - 10/2015
6	Peptides (Polypeptides)IBA 02/2022 - 11/2017
6	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2021 - 03/2015
6	Hyaluronic Acid (Hyaluronan)IBA 05/2020 - 06/2014
6	Proteins (Proteins, Gene)FDA Link 01/2018 - 08/2013
5	Polylactic Acid-Polyglycolic Acid CopolymerIBA 04/2021 - 01/2011
5	Interleukin-6 (Interleukin 6)IBA 12/2020 - 09/2017
5	Adenosine (Adenocard)FDA LinkGeneric 10/2020 - 06/2016
5	MicroRNAs (MicroRNA)IBA 12/2018 - 11/2015
5	PolymersIBA 01/2018 - 10/2014
5	AlbuminsIBA 12/2016 - 08/2009
5	Human Serum Albumin FDA LinkGeneric 12/2016 - 07/2013
5	methotrexate-serum albuminIBA 09/2012 - 01/2011
4	carboxymethyl dextranIBA 04/2022 - 05/2020
4	LigandsIBA 01/2022 - 01/2011
4	Polyethylene Glycols (Polyethylene Glycol)FDA LinkGeneric 04/2021 - 07/2019
4	AntigensIBA 04/2021 - 01/2011
4	Gemcitabine FDA Link 11/2020 - 01/2016
4	Biotin (Vitamin H)FDA Link 05/2017 - 01/2011
4	Paclitaxel (Taxol)FDA LinkGeneric 12/2016 - 10/2010
3	Liposomes (Liposome)IBA 02/2022 - 01/2022
3	CytokinesIBA 02/2022 - 01/2017
3	CateninsIBA 02/2022 - 06/2018
3	InterleukinsIBA 02/2022 - 01/2017
3	STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA 01/2022 - 05/2020
3	Sirolimus (Rapamycin)FDA Link 01/2022 - 08/2016
3	IronIBA 01/2022 - 12/2013
3	Fibroins (Fibroin)IBA 01/2021 - 10/2014
3	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 09/2020 - 12/2017
3	VimentinIBA 05/2020 - 09/2016
3	LipidsIBA 01/2019 - 12/2017
3	Glucose (Dextrose)FDA LinkGeneric 01/2019 - 12/2017
3	Amyloid beta-PeptidesIBA 01/2018 - 12/2013
3	Irinotecan (Camptosar)FDA LinkGeneric 05/2017 - 06/2010
3	Drug CarriersIBA 12/2016 - 07/2013
3	Biological ProductsIBA 07/2016 - 10/2014
3	Trastuzumab (Herceptin)FDA Link 03/2015 - 01/2011
3	Gonadotropin-Releasing Hormone (GnRH)FDA Link 07/2012 - 01/2010
2	Transferrin Receptors (Transferrin Receptor)IBA 02/2022 - 01/2022
2	IntegrinsIBA 01/2022 - 01/2021
2	Therapeutic UsesIBA 01/2022 - 06/2017
2	arginyl-glycyl-aspartic acidIBA 01/2022 - 01/2021
2	Biomarkers (Surrogate Marker)IBA 04/2021 - 11/2017
2	Dinoprostone (PGE2)FDA Link 01/2021 - 08/2013
2	Glycoproteins (Glycoprotein)IBA 12/2020 - 06/2020
2	AlginatesIBA 12/2020 - 12/2020
2	dinaciclibIBA 10/2020 - 09/2020
2	graphene oxideIBA 09/2020 - 01/2018
2	maleimideIBA 06/2020 - 01/2011
2	Interleukin-10 (Interleukin 10)IBA 05/2020 - 01/2017
2	Transforming Growth Factors (Transforming Growth Factor)IBA 05/2020 - 10/2018
2	Dextrans (Dextran)FDA Link 12/2018 - 01/2017
2	Oxygen (Dioxygen)IBA 01/2018 - 12/2017
2	ferulic acid (sodium ferulate)IBA 01/2018 - 06/2017
2	NucleoproteinsIBA 01/2018 - 09/2012
2	Ethylene Glycol (Monoethylene Glycol)IBA 11/2017 - 05/2016
2	cabazitaxel FDA Link 11/2017 - 01/2017
2	Cadherins (E-Cadherin)IBA 08/2017 - 09/2016

Therapy/Procedure

32	Therapeutics 02/2022 - 01/2010
11	Drug Therapy (Chemotherapy) 02/2022 - 12/2011
7	Immunotherapy 02/2022 - 07/2014
4	Precision Medicine 10/2019 - 07/2016
3	Aftercare (After-Treatment) 01/2019 - 01/2011
3	Photothermal Therapy 01/2018 - 07/2016
2	Ligation 01/2021 - 10/2020
2	Lasers (Laser) 01/2020 - 01/2018
2	Intravitreal Injections 01/2020 - 08/2013